Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer

Anticancer Research

Volumn 33, Issue 5, 2013, Pages 2233-2238

  Gruber, Ines V ^a   Landenberger, Nicole ^b   Staebler, Annette ^a   Hahn, Markus ^a   Wallwiener, Diethelm ^a   Fehm, Tanja ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Breast cancer; Circulating tumor cell; FAS; Immunosurveillance; T cell; Tumor cell dormancy

Indexed keywords

CD28 ANTIGEN; FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GRADING; CIRCULATING TUMOR CELL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOREGULATION; MAJOR CLINICAL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; QUANTITATIVE ASSAY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

BREAST CANCER; CIRCULATING TUMOR CELL; FAS; IMMUNOSURVEILLANCE; T-CELL; TUMOR CELL DORMANCY;

ANTIGENS, CD95; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; T-LYMPHOCYTE SUBSETS; TUMOR ESCAPE;

EID: 84878175404     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Zhao S, Liu Y, Zhang Q, Li H, Zhang M, Ma W, Zhao W, Wang J and Yang M: The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: A meta-analysis of published literature. Breast Cancer Res Treat 130(3): 809-816, 2011.
2. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE and Vogelstein: The genomic landscapes of human breast and colorectal cancers. Science 318(5853): 1108-1113, 2007.
3. Klein CA and Holzel D: Systemic cancer progression and tumor dormancy: Mathematical models meet single cell genomics. Cell Cycle 5(16): 1788-1798, 2006. (Pubitemid 44435321)
4. North S, Moenner M and Bikfalvi A: Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. Cancer Lett 218(1): 1-14, 2005. (Pubitemid 40082696)
5. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R and Harris AL: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57(5): 963-969, 1997. (Pubitemid 27098025)
6. Campoli M, Ferrone S, Zea AH, Rodriguez PC and Ochoa AC: Mechanisms of tumor evasion. Cancer Treat Res 123: 61-88, 2005.
7. Salih HR and Nussler V: Commentary: Immune escape versus tumor tolerance: How do tumors evade immune surveillance? Eur J Med Res 6(8): 323-332, 2001.
8. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL and Banham AH: Quantification of regulatory T-cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. JClinOncol 24(34): 5373-5380, 2006. (Pubitemid 46623168)
9. Gruber IV, El Yousfi S, Durr-Storzer S, Wallwiener D, Solomayer EF and Fehm T: Down-regulation of CD28, TCR-zeta (ζ) and Up-regulation of FAS in Peripheral Cytotoxic T-cells of Primary Breast Cancer Patients. Anticancer Res 28(2A): 779-784, 2008. (Pubitemid 351578921)
10. + peripheral blood T-lymphocytes of patients with melanoma. Clin Cancer Res 7(3Suppl): 947s-957s, 2001
11. Demel U, Tilz GP, Foeldes-Papp Z, Gutierrez B, Albert WH and Bocher O: Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay. J ExpClin Cancer Res 23(3): 465-468, 2004. (Pubitemid 39490631)
12. Zieglschmid V, Hollmann C, Gutierrez B, Albert W, Strothoff D, Gross E and Bocher O: Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res 25(3A): 1803-1810,2005. (Pubitemid 40896806)
13. Lankiewicz S, Gutierrez, Rivero B and Bócher O: Quantitative realtime RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment. Mol Biotechnol 34(1): 15-27, 2006. (Pubitemid 44337216)
14. Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R and Kasimir-Bauer S: Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells: Breast Cancer Res 11: R59, 2009.
15. Rabinovich H, Reichert TE, Kashii Y, Gastmann BR, Bell MC and Whiteside TL: Lymphocyte apoptosis induced by FAS ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest 101(11): 2579-2588, 1998. (Pubitemid 28270452)
16. Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N,Gooding W, Johnson JT and Whiteside TL: Spontaneous apoptosis of circulating T-lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8(8): 2553-2562, 2002. (Pubitemid 34856339)
17. Reichert TE, Strauss L, Wagner EM, Gooding W and Whiteside TL: Signaling abnormalities, apoptosis and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 8(10): 3137-3145, 2002. (Pubitemid 35155023)
18. Müschen M, Moers C, Warskulat U, Even J, Niederacher D and Beckmann MW: CD95 ligand expression as a mechanism of immune escape in breast cancer. Immunology 99(1): 69-77, 2000. (Pubitemid 30062940)
19. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin JL, Vivier E, Anderson P and Kiessling R: Decreased expansion of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53(23): 5610-5612, 1993. (Pubitemid 23360258)
20. Zhang B, Sun T, Xue L, Han X, Zhang B, Lu N, Shi Y, Tan W, Zhou Y, Zhao D, Zhang X, Guo Y and Lin D: Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis 28(5): 1067-1073, 2007. (Pubitemid 47072192)
21. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH and Galle PR: Lymphocytes apoptosis induced by CD95 (APO-1/FAS) ligand expressing tumor cells-A mechanism of immune evasion ? Nat Med 2(12): 1361-1366, 1996.
22. Keene JA and Forman J: Helper activity is required for the in vivo generation of cytotoxic T-lymphocytes. J Exp Med 155(3): 768-782, 1982. (Pubitemid 12187851)
23. + T-lymphocytes. Nature 421(6925):852-856, 2003.
24. Shedlock DJ and Shen H: Requirement for CD4 T-cell help in generating functional CD8 T-cell memory. Science 300(5617): 337-339, 2003. (Pubitemid 36433726)
25. + T-cells after acute infection. Nat Immunol 5(9): 927-933. 2004.
26. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW and Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8): 781-791, 2004. (Pubitemid 39095313)
27. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN and Terstappen LW: Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23(7): 1420-1430, 2005.
28. Kurt RA, Urba WJ, Smith JW and Schoof DD: Peripheral T-lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules. Int J Cancer 78(1): 16-20, 1998. (Pubitemid 28391668)
29. Melichar B, Tousková M, Dvorák J, Jandík P and Kopecký O: The peripheral blood leukocyte phenotype in patients with breast cancer: Effect of doxorubicin/paclitaxel combination chemotherapy. Immunopharmacol Immunotoxicol 23(2):163-173, 2001. (Pubitemid 32532044)
30. Luca PJ, Negishi I, Nakayama K, Fields LE and Loh DY: Naïve CD28-deficient T-cells can initiate but not sustain an in vitro antigen-specific immune resonse. J Immunol 154(11): 5757-5768, 1995.
31. Gudmundsdottir H, Wells AD and Turka LA: Dynamicy and requirements of T cell clonal expansion in vivo at the single-cell level: Effector function is linked to proliferation capacity. J Immunol 162(9): 5212-5223, 1999. (Pubitemid 29307126)
32. Kahn HJ, Yang LY, Blondal J, Lickley L, Holloway C, Hanna W, Narod S, McCready DR, Seth A and Marks A: RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: Correlation with established prognostic parameters. Breast Cancer Res Treat 60(2): 143-151, 2000. (Pubitemid 30307474)
33. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis Ch, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D and Georgoulias V: Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance. J Clin Oncol 20(16): 3404-3412, 2002.
34. Ignatiadis M, Perraki M, Apostolaki S, Politaki E, Xenidis N, Kafousi M, Stathopoulos E, Lianidou E, Sotiriou C, Georgoulias V and Mavroudis D: Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer. Clin Breast Cancer 7(11): 883-889, 2007.
35. Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias V and Mavroudis D: Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res 14(9): 2593-2600, 2008.
36. Ferro P, Franceschini MC, Bacigalupo B, Dessanti P, Falco E, Fontana V, Gianquinto D, Pistillo MP, Fedeli F and Roncella S: Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: Association with clinical prognostic factors. Anticancer Res 30(6): 2377-2382, 2010.
37. Fehm T, Mueller V, Marches R, Klein G, Guckel B, Neubauer H, Solomayer E and Becker S: Tumor cell dormancy: Iimplications for biology and treatment of breast cancer. APMIS 116(7-8): 742-753, 2008.